Source: Annals of Hepatology. Unidade: FM
Subjects: NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR, EVENTO ADVERSO A MEDICAMENTO, MANIFESTAÇÕES CUTÂNEAS, ANTINEOPLÁSICOS
ABNT
BRANCO, Fernanda et al. The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Annals of Hepatology, v. 16, n. 2, p. 263-268, 2017Tradução . . Disponível em: https://doi.org/10.5604/16652681.1231585. Acesso em: 23 maio 2024.APA
Branco, F., Alencar, R. S. M., Volt, F., Sartori, G., Dode, A., Kikuchi, L., et al. (2017). The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Annals of Hepatology, 16( 2), 263-268. doi:10.5604/16652681.1231585NLM
Branco F, Alencar RSM, Volt F, Sartori G, Dode A, Kikuchi L, Tani CM, Chagas AL, Pfiffer T, Hoff P, Carrilho FJ, Mattos AA de. The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib [Internet]. Annals of Hepatology. 2017 ; 16( 2): 263-268.[citado 2024 maio 23 ] Available from: https://doi.org/10.5604/16652681.1231585Vancouver
Branco F, Alencar RSM, Volt F, Sartori G, Dode A, Kikuchi L, Tani CM, Chagas AL, Pfiffer T, Hoff P, Carrilho FJ, Mattos AA de. The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib [Internet]. Annals of Hepatology. 2017 ; 16( 2): 263-268.[citado 2024 maio 23 ] Available from: https://doi.org/10.5604/16652681.1231585